[#item_full_content] The Drug Enforcement Administration’s chief administrative law judge has stayed the marijuana rescheduling proceeding while he considers a motion to add a new Government Accountability Office report on federal drug-scheduling procedures to the hearing record. Responses to the motion are due October 13, 2026. The stay delays the judge’s recommended decision on moving marijuana to Schedule III, but it does not affect the April 2026 order covering FDA-approved marijuana products and marijuana subject to a state medical marijuana license.
Read More